Although in different types of cancers tetraspanins may interact with different partners and function discordantly, with the consistent role of TSPAN8 and its upregulation in HCC, it may also be a promising therapeutic target via a highly specific antibody. The gene discussed is TSPAN8; the disease is cancer.